Warning letter
Jiangsu Hengrui Medicine Co. LTD.: warning letter of Nov 29, 2000
FDA warning letter UCM069073 · Center for Drug Evaluation and Research
Key facts
| Reference number | UCM069073 |
|---|---|
| Company | Jiangsu Hengrui Medicine Co. LTD. |
| Subject | Good Manufacturing Practices for Active Pharmaceutical Ingredient |
| Issue date | Nov 29, 2000 |
| Posted date | Nov 29, 2000 |
| Issuing office | Center for Drug Evaluation and Research |
| Product type | Drugs |
| Country | 3 |
| Inspection city | Lianyungang |
| Inspection start date | Sep 11, 2000 |
| Letter on fda.gov | web.archive.org |
At a glance
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: